Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relationship between lipoprotein(a) phenotypes and plaminogen activator inhibitor type 1 in diabetic patients.

Thrombosis research - 15 Jul 2000

Hernández C, Chacón P, García-Pascual L, Mesa J, Simó R

Abstract excerpt

It has been demonstrated in vitro that lipoprotein(a) [Lp(a)] increases the endothelial synthesis of plasminogen activator inhibitor 1 (PAI-1). However, this effect in vivo is controversial, and the possible relationship between PAI-1 and Lp(a) phenotypes has not been evaluated. The aim of the study was to determine the influence of Lp(a) and its phenotypes on PAI-1 serum concentrations in diabetic patients. For...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens
Share to Diabetes Mellitus
Share to Diabetes Mellitus, Type 1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 2

Share to Lipoprotein(a)

Share to Plasminogen Activator Inhibitor 1

Share to Regression Analysis

Share to Triglycerides

Source

Identifiers

PMID: 10946085
DOI: 10.1016/s0049-3848(00)00248-6

Genes

SDS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relationship between lipoprotein(a) phenotypes and plaminogen activator inhibitor type 1 in diabetic patients.PMID 10946085Read ↗

Relationship between lipoprotein(a) phenotypes and albumin excretion rate in non-insulin-dependent diabetes mellitus: protective effect of 'null' phenotype?Semantic proximity Read ↗

Relationship of lipoprotein(a) and its phenotypes with the albumin excretion rate in diabetic patients: a multivariate analysis.Semantic proximity Read ↗

Normal lipoprotein(a) concentrations and apolipoprotein(a) isoforms in patients with insulin-dependent diabetes mellitus.Semantic proximity Read ↗

Determination of lipoprotein(a) concentrations and apolipoprotein(a) molecular weights in diabetic patients.Semantic proximity Read ↗

Lipoprotein (a) phenotype distribution in a population of bypass patients and its influence on lipoprotein (a) concentration.Semantic proximity Read ↗

Lipoprotein(a) levels and apolipoprotein(a) isoforms related to life style risk factors.Semantic proximity Read ↗

Reference values of plasma lipoprotein (a) in newly classified apolipoprotein(a) phenotype groups in the Japanese population.Semantic proximity Read ↗

Studies on apolipoprotein(a) phenotypes. Part 2. Phenotype frequencies and Lp(a) concentrations in different phenotypes in patients with angiographically defined coronary artery diseases.Semantic proximity Read ↗

[Genetic-epidemiological studies of apolipoprotein(a) polymorphism and its significance in nephrological diseases and type I diabetes mellitus].Semantic proximity Read ↗

Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients.Semantic proximity Read ↗

[Relationship between lipoprotein A, apolipoprotein A and their isoforms in parents and children].Semantic proximity Read ↗

PAI-1 activity, but not fibrinogen or von Willebrand factor, is inversely related to LDL particle size in type 2 diabetes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.